Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
Go back to Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.85 -0.15 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $44.38 | |||
| Open | $8.14 | 52 Week Low | $24.47 | |||
| Day High | $8.26 | P/E | 392.50 | |||
| Day Low | $7.83 | EPS | $0.02 | |||
| Volume | 1,557,965 | |||||
